 46 PM / Updated 12 minutes ago BRIEF-Prokaryotics Announces Licensing Agreement With Merck For Novel Investigational Antibiotic Candidates Reuters Staff 
Jan 25 (Reuters) - Merck & Co Inc: 
* PROKARYOTICS ANNOUNCES LICENSING AGREEMENT WITH MERCK FOR NOVEL INVESTIGATIONAL ANTIBIOTIC CANDIDATES 
* PROKARYOTICS - ANNOUNCES LICENSING AGREEMENT WITH MERCK FOR NOVEL INVESTIGATIONAL ANTIBIOTIC CANDIDATES 
* PROKARYOTICS - CO GAINS WORLDWIDE RIGHTS TO DEVELOP EARLY PRE-CLINICAL PROGRAMS FOR GRAM-NEGATIVE, GRAM-POSITIVE BACTERIAL CELL ENVELOPE ENZYMES 
* PROKARYOTICS - SPECIFIC TERMS OF AGREEMENT WERE NOT DISCLOSED Source text for Eikon: Further company coverage: